Clinical Trials Directory

Trials / Conditions / Metabolic Dysfunction-Associated Steatotic Liver Disease

Metabolic Dysfunction-Associated Steatotic Liver Disease

66 registered clinical trials studyying Metabolic Dysfunction-Associated Steatotic Liver Disease53 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingHuman Models of Selective Insulin Resistance: Pancreatic Clamp
NCT06558422
Columbia UniversityPhase 1
Not Yet RecruitingHow Abnormal Function of Fat Tissue in Type 1 Diabetes Contributes to Fat in the Liver
NCT07133854
Université de SherbrookeN/A
Not Yet RecruitingSMART Diets for MASLD
NCT07459504
Corewell Health WestPhase 2
Not Yet RecruitingSamsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD)
NCT07530419
Seoul National University Hospital
Not Yet RecruitingImpact of Circadian Exercise on Metabolic Dysfunction-Associated Steatotic Liver Disease in Postmenopausal Wom
NCT07386665
Universidad de AlmeriaN/A
RecruitingA Large Language Model-based Chatbot for Alcohol Reduction in Patients With Metabolic Alcohol-Related Liver Di
NCT07450144
The University of Hong KongN/A
RecruitingAdvanced Fibrosis Detection for MASLD in Primary Care
NCT07159386
Medical University of South CarolinaN/A
Not Yet RecruitingMPV as a Predictor for ACS in Patients With MASLD
NCT07487571
Sohag University
Not Yet RecruitingUsing Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalis
NCT07430501
Hospital Universitari Vall d'Hebron Research Institute
RecruitingEfficacy and Safety of Rifaximin-α in Treating MASLD
NCT07381257
Shanghai Changzheng HospitalEARLY_Phase 1
Not Yet RecruitingUltrasound Liver Imaging for Classification of Metabolic Dysfunction-associated Steatotic Liver Disease
NCT07373769
University of British Columbia
Not Yet RecruitingImproving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the ED
NCT06944353
Northwestern UniversityN/A
Enrolling By InvitationAssessment of Non-Invasive Testing in Major Liver-Related Outcomes
NCT06986447
HRI-MAIL-NIT
RecruitingA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (
NCT07165028
Eli Lilly and CompanyPhase 3
CompletedDigital Pathology and AI for Liver Outcomes in MASLD (DPAILO-2)
NCT06493253
PharmaNest, Inc
CompletedDigital Pathology and AI for Liver Outcomes in MASLD
NCT06344364
PharmaNest, Inc
Not Yet RecruitingClinical Efficacy of Pegylated Interferon Alpha-2b Combined With Nucleos(t)Ide Analogues in the Treatment of C
NCT07071636
Shenzhen Third People's HospitalPhase 4
Not Yet RecruitingPrognostic Model for MASLD Related Cirrhosis
NCT07082751
Beijing Friendship Hospital
Not Yet RecruitingReducing Barriers to Lifestyle Modification for Newly Diagnosed MASLD
NCT06483711
Stanford UniversityN/A
RecruitingEffect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
NCT06138821
Pichamol Jirapinyo, MD, MPHN/A
RecruitingQuantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD
NCT07192159
Seoul National University HospitalN/A
Not Yet RecruitingEffect of In-Place Slow Jogging on Metabolic Dysfunction-Associated Steatotic Liver Disease
NCT06994234
Shanghai East HospitalN/A
RecruitingThe Establishment of Hong Kong Diabetes Steatotic Liver Disease Register
NCT07437157
Chinese University of Hong Kong
RecruitingThe Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health
NCT07093346
University of NottinghamN/A
RecruitingAspirin for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
NCT06935994
Taichung Veterans General HospitalPhase 2
Not Yet RecruitingDigital Diet and Exercise Intervention to Reduce Liver Fibrosis in Metabolic Dysfunction-associated Steatotic
NCT06920316
St. George's Hospital, LondonPhase 4
RecruitingA Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Dise
NCT06836609
Regeneron PharmaceuticalsPhase 1
Enrolling By InvitationEffect on Body Weight Reduction of a Behavioral Intervention on Lifestyle Using a Digital Nutritional Program
NCT07456332
Hospital Universitari de BellvitgeN/A
RecruitingStudy of the Link Between MASH ( Metabolic Dysfunction-Associated Steatohepatitis) and MAMs (Mitochondria-Asso
NCT06868992
Hospices Civils de Lyon
Enrolling By InvitationMetabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia
NCT07001865
Ningbo No. 1 Hospital
RecruitingAccelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population
NCT06984510
Ningbo No. 1 Hospital
Enrolling By InvitationEffects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With
NCT07274644
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolPhase 4
Enrolling By InvitationEffects of Different Exercises on Intrahepatic Lipid in Patients With Metabolic Dysfunction-associated Steatot
NCT06994871
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolN/A
Not Yet RecruitingKorean Health Screening-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Registry
NCT06843421
Korea University
WithdrawnA Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH
NCT06692283
Sagimet Biosciences Inc.Phase 3
RecruitingEffect of Indianized Version of Mediterranean Diet vs. Low Fat Diet on Hepatic Steatosis in Overweight Childre
NCT06768216
Institute of Liver and Biliary Sciences, IndiaN/A
Not Yet RecruitingClinical Classification of MAFLD Based Liver Biopsy
NCT06795646
Beijing Friendship Hospital
Active Not RecruitingFeasibility of the Paso Program for Patients With Metabolic Dysfunction Associated Steatotic Liver Disease
NCT06854185
Baylor College of MedicineN/A
RecruitingDevelopment of Microbial Therapeutics for Metabolic-associated Fatty Liver Disease: From Mechanistic Investiga
NCT06873165
National Taiwan University HospitalN/A
RecruitingDeveloping Microbial Therapy for MASLD: From Mechanism to Clinical Validation
NCT07488975
Leeuwenhoek Laboratories Co. Ltd.Phase 1
RecruitingCOmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic
NCT06704516
University of OxfordPhase 1
Not Yet RecruitingHenagliflozin on Liver Fibrosis in Patients with MASLD and T2DM
NCT06762223
Xiqiao ZhouPhase 4
RecruitingEffect of a GnRH Analog on Hepatic Steatosis
NCT06523530
Aristotle University Of ThessalonikiPhase 4
Not Yet RecruitingLiver Fibrosis Assessment in Diabetic Patients
NCT06694974
National Taiwan University HospitalN/A
RecruitingPrognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH
NCT06813508
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not Yet RecruitingImpact of Live Streaming Exercise on Liver Health in MASLD Pregnant Women
NCT06682663
Peking UniversityN/A
Not Yet RecruitingTargeting the Skeletal Muscle to Treat Metabolic Dysfunction-associated Steatotic Liver Disease
NCT06506513
Cliniques universitaires Saint-Luc- Université Catholique de LouvainN/A
RecruitingMetabolic Features Effects on FAST Score in MASLD Patients
NCT06867419
Tanta University
Not Yet RecruitingStudy of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Sohag University Employees
NCT06536933
Sohag University
RecruitingHyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases
NCT06619808
Jinling Hospital, ChinaN/A
CompletedAlternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MAS
NCT06482112
Merck Sharp & Dohme LLCPhase 2
RecruitingPattern of Cardiac Arrhythmia in Patients With MASLD
NCT06490432
Sohag University
Active Not RecruitingA Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)
NCT06465186
Merck Sharp & Dohme LLCPhase 2
RecruitingFecal Microbiota Analysis of PNPLA3 Polymorphism in Hispanic Patients With MASLD
NCT06495333
Fundacion de Investigacion Science and Education
RecruitingEffect of High Intensity Exercise Rehabilitation on Liver Function and Insulin Sensitivity in Patients With MA
NCT06359444
University GhentN/A
UnknownRisk Factors and Impact MASLD in Patients With IBD
NCT06328452
Assiut University
Enrolling By InvitationGuerbet Liver Fibrosis
NCT06703450
Icahn School of Medicine at Mount Sinai
Active Not RecruitingNon-Invasive Diagnostic Tests for MASLD in Pediatric Population
NCT06218589
Emory UniversityN/A
RecruitingInfluence of Metabolic Syndrome on Endogenous Oxalate Synthesis
NCT06735924
University of Alabama at BirminghamN/A
CompletedProbiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults MASLD Patients (DELI_MASLD Study)
NCT06352697
Bogomolets National Medical UniversityN/A
RecruitingLiver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabete
NCT07083336
State Key Laboratory of Subhealth Intervention TechnologyN/A
CompletedLifestyle Habits and Metabolic Dysfunction-Associated Steatotic Liver Disease in Youth
NCT07095010
Harokopio University
CompletedThe Impact of Nutrition Education and Rice Bran Supplementation on Metabolic Dysfunction-associated Steatotic
NCT07524621
Shih Chien UniversityN/A
Enrolling By InvitationInvestigating Myosteatosis in Steatotic Liver Diseases
NCT06514300
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
CompletedAntidiabetic Drugs for Steatotic Liver Disease
NCT03646292
Yonsei UniversityPhase 4
CompletedRisk Factors and Prediction Model for Liver-Related Outcomes in Elderly Patients With Steatotic Liver Disease
NCT07537829
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School